Ankerstar Wealth’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23
Closed -$572 – 1070
2026
Q2
$572 Hold
23
– – ﹤0.01% 614
2026
Q1
$322 Buy
23
+19
+475% +$256 ﹤0.01% 737
2025
Q4
$45 Buy
+4
New +$46 ﹤0.01% 1020

Other funds holding AVNS

Ankerstar Wealth's AVNS Position: Q3 2026 in Review

Ankerstar Wealth sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 23 shares — an estimated $572 sold.

Ankerstar Wealth first reported a position in AVNS in Q4 2025 and held it in 3 quarters. The position peaked at $572 in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Ankerstar Wealth reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Ankerstar Wealth sold 23 Avanos Medical shares in Q3 2026, an estimated $572.
  • Ankerstar Wealth first reported a position in Avanos Medical in Q4 2025 and held it in 3 quarters.
  • Ankerstar Wealth's Avanos Medical position peaked at $572 in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.